{"name":"Centessa Pharmaceuticals (UK) Limited","slug":"centessa-pharmaceuticals-uk-limited","ticker":"","exchange":"","domain":"centessauk.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":15000000,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":-197532000,"cash":61299000,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2025"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"ORX142 Tablets","genericName":"ORX142 Tablets","slug":"orx142-tablets","indication":"Other","status":"phase_1"},{"name":"ORX750","genericName":"ORX750","slug":"orx750","indication":"Other","status":"phase_2"}]}],"pipeline":[{"name":"ORX142 Tablets","genericName":"ORX142 Tablets","slug":"orx142-tablets","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"ORX750","genericName":"ORX750","slug":"orx750","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMib0FVX3lxTE9fTVhONUpFWUNJWUNFRmdTM29ORE13MC1HMjhNaG9wbk1wNnJOb2s5b1AxT1lQdHZaUE9ObDQ5U243YzJjdmdWX3p0dWUxUFFWaE1faHl5SWQycjA3elE3NVBQLTNSMWk0cHBVMjVBaw?oc=5","date":"2026-04-01","type":"pipeline","source":"medwatch.com","summary":"UK authority recommends Wegovy to reduce heart risks - medwatch.com","headline":"UK authority recommends Wegovy to reduce heart risks","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAFBVV95cUxOeXYyZk1KTWtzbnFNNzZDZGZ6Z3MxQ1hkZm9kcXNORkNJeVprMFd0OEIyd0M3NTRSNGRuZHFuVXFMNnBUNkxxT0pHQTZNY1NwR1ByQmtiWGZlLS0teFh4MXgyNlp3QWxfNDRNLUdFUVlReENabkN2VGktR2hvaWdGOQ?oc=5","date":"2026-04-01","type":"pipeline","source":"PharmTech.com","summary":"Why Lilly Paid $6.3 Billion for Sleep Science - PharmTech.com","headline":"Why Lilly Paid $6.3 Billion for Sleep Science","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxOa0poOXpWNEYwTXZNaTB2SzRlNjNNMWhyUmMtVDN4UGhabFQtOExESkQ2Q3ZnS1V4aVAyQUVQWl9XUXlweEt1VDM1ZExVZjVYaGJVVGdVbV9TSWw3a3BpOGdUUllGamRSNGMzdFhIQWhudF9BbUtyb2xFdWFkTS02amlNTFhzYzZIU3NEUXBRa2dvUTVwWXJ5WE9wUk9wU1QxUnpZV0FyRE5vSVdKR0dR?oc=5","date":"2026-04-01","type":"deal","source":"Business Weekly","summary":"Cambridge research leads to $7.8bn mega-deal as Lilly swoops for Centessa - Business Weekly","headline":"Cambridge research leads to $7.8bn mega-deal as Lilly swoops for Centessa","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwwFBVV95cUxPWGdabzJ4dnlUYkNmYlQwek51N0Z3Nm9kd3pwaUdaZDRYQUx6cXBqZnhOZTk1STdUZGdzTXJXZHVRVFkwNVVqN3dCZktxSUNpV205cHRwdzA1OUJWNHFZbjlFd3BueTBLZFNVanNnU3E0WGpBS1dGbHV2SG94MTd5b1UyLWtsZ0dCLVNIUEtlRGxnVk9VSmRvWHVOb3l1dTBMay0yaklDd05teHhsS3JSSEV1X3dSaXYxWG1qRS16QTZpR0E?oc=5","date":"2026-03-31","type":"deal","source":"Eli Lilly","summary":"Lilly to acquire Centessa Pharmaceuticals to advance treatments for sleep-wake disorders | Eli Lilly and Company - Eli Lilly","headline":"Lilly to acquire Centessa Pharmaceuticals to advance treatments for sleep-wake disorders | Eli Lilly and Company","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2wFBVV95cUxNUDY4YUQ1N1JoZzV0X3BPS1R1VjJNd3ZyT1JRb2RDTjBKOGVzZm9teUM5ZFF3M00xb3BYcWJCLWdIX0FkVmpRU2RBZHB0THFxMG5PblFnUGVwdGswWTVXVFFEZUpDZU1JeXhPU1NENEg5MjJ5aVVCOUViVjA1MWRVdkZLb3NYMzluWC1qcDVud0FSTGNZX3FwQWo4R1NrS21QM296MFkteFRnY1NzVWJxMkhGSzN5TG96NVVVRzUtUEN2SF9xMzZsZzN6VGtfTGhoMkgtMFJIWVpOSHM?oc=5","date":"2026-03-31","type":"deal","source":"GlobeNewswire","summary":"Nxera Pharma’s Partner Centessa Pharmaceuticals to be Acquired by Lilly - GlobeNewswire","headline":"Nxera Pharma’s Partner Centessa Pharmaceuticals to be Acquired by Lilly","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMib0FVX3lxTE56Q09MMi0xSWI2WGdKM0plQlNQV25jbmxiSG51WHFtb3EzTkpaMTBCMUpxeDZBbDVUMUJSVUhteTlwWG9mY3J2LWZDYjByUm1KanpHOXg5OThfUUVmaGRYSTB2dlR3dS1KVUFFOEhfQQ?oc=5","date":"2026-03-31","type":"deal","source":"medwatch.com","summary":"Eli Lilly buy US biotech Centessa for up to USD 7.8bn - medwatch.com","headline":"Eli Lilly buy US biotech Centessa for up to USD 7.8bn","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxPa1BXYlRNd0lsV0JZVzZUQmw4Qk5yTVdmby1nZmJRVDJUdDh5a2k4eEFtMWdjdWxqdEJSaXFqMkRfaUdKc0xNcWlGZXBiZnJ6bGxzSGxOU25YM3RRT2hISjBRLTc5bWhwamFLMVJWVnNGWjFVSVk5dXpHVUtseFdiYjcxU01jRVRJMFlqei03ZkxmNGs3TmpJa0VrVmNrRWt0eVJwOXdObFhETGNXbzhXLUxWNkJkQQ?oc=5","date":"2026-03-31","type":"deal","source":"Stock Titan","summary":"Lilly to acquire Centessa (NASDAQ: CNTA) as orexin sleep pipeline advances - Stock Titan","headline":"Lilly to acquire Centessa (NASDAQ: CNTA) as orexin sleep pipeline advances","sentiment":"neutral"},{"date":"2026-03-31","type":"earnings","source":"SEC EDGAR","summary":"10-K filed with SEC: 10-K","headline":"Annual Report (10-K) Filed","sentiment":"neutral"},{"date":"2026-03-31","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiekFVX3lxTE80QW5RQU5KUV9ZQ0d5a3B3WmNUSk5WbnFRdElHUDd1WGZ4bE9NUE9mS1pxUXA2UjhvNEd2WkN5SVlhel83ZUVTalBPblpzcTN0bVRnSjZBX1BMdHItQ3N2Y0s3NzBnTEh0bjg5Y0MxTmpYYVNXM2dJMVJ3?oc=5","date":"2026-02-12","type":"pipeline","source":"Yahoo Finance","summary":"Nxera Pharma to Receive $1.8 Million Milestone Payment from Centessa Pharmaceuticals - Yahoo Finance","headline":"Nxera Pharma to Receive $1.8 Million Milestone Payment from Centessa Pharmaceuticals","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxNaWJCOWV1YXc4czA3NWhHbkNxbi1hcG9SaXlMcnFfMnlXemVjQjg2N1NRYkZ1UkFESEFZSEhZODZKOGFRWTRHYUNYTmVic2dNWHJLbko1ZHJyMGVjRDNmTDRQY1lZd3Q1TWpzdXgwM1pTU3RpbWNKVzRJaWtYYkd2ZkNhYWtXeU1SVEk5MnFDOGtZU3NjRnJWT1pCSzRDemxnNEpBMGUwandoNjhfMGZxMjBvU2NKeXhkTlE?oc=5","date":"2025-11-06","type":"pipeline","source":"Contract Pharma","summary":"Alvotech, Advanz Pharma Receive MHRA Marketing Authorizations for Gobivaz - Contract Pharma","headline":"Alvotech, Advanz Pharma Receive MHRA Marketing Authorizations for Gobivaz","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxPUmZ5MWJ1UnRfVzA5VjlycDlKQm5VUDR6X1k2ZWdwV3k0V0FBVmNxRFhTQnI4ZklMMUt3emlhV3BYMjNDMWRpS3VUMlY4amFRSDI2WV82cFE1ZHBWT0lsekRKZUZkQzliMWUzdGhzYzFFZjNaMDlJUl9RTDNRWDBjaGpIeEtocngwS0xXZGwtZ2RyUHhKdkh0R1J1MA?oc=5","date":"2025-07-14","type":"regulatory","source":"BioPharma Dive","summary":"Takeda to seek approval of new kind of narcolepsy drug after study data - BioPharma Dive","headline":"Takeda to seek approval of new kind of narcolepsy drug after study data","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxQX0ZLbldHSk1USmZBMDMwb1YyQ2ZSRGdTV09pd3NrVXA3a2liczBFbk5FNTdJMmFab0ZBUmdwQ05oOXVSWGtvbU5EaU5ySm55NUpIZmxrMW1VS3ZSUnZ2NzkxT25nanFUaXRIbWxZN2Jmc1Mwb21GRTluVDdRZnEtQXNFelRQMnU4VHRJcVkzcnVkQXBOSjNCVXJpY0tzSkpfVWVFSk1Sc0l6OVd5NWc?oc=5","date":"2021-06-23","type":"pipeline","source":"Pharmaceutical Technology","summary":"Centessa Pharmaceuticals: forging a new path for pharma R&D - Pharmaceutical Technology","headline":"Centessa Pharmaceuticals: forging a new path for pharma R&D","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwJBVV95cUxNQjBXeUNHdElldjJRZ0gtVUxTNFdaNWtjTnpCbFBhU2NJMVMyNWlSS2U0YTRfcnR0bTRoNVhfZHBMZC1zOUJIUHA4UlpaZVQ0TzUyajA1d0EwYnNpMmlsdE8tMkpaUEFfd2JlUzVqMlhCWkVMZng0amlCWVNPWGJ0bDFzUTZ0MF9mNXJCdU90cWZ0ODYtcF9EZC1pQ0tZbFl3WmRBNFpua3RSeFRtX3NsYVlxZU1VTFVUUVdxbUNiVU9KYlhaU19vR0RvSVBfMDhYbUZlMlJla1A0cndSbExHMzUtYWtPYTNLUzZLckhteUV0VU1sREhNYkZyeHd1YWExVGVfRHRLZXBsYjA?oc=5","date":"2021-02-16","type":"pipeline","source":"Business Wire","summary":"Centessa Pharmaceuticals Launches with $250 Million Series A Financing and Unveils a New Kind of Pharmaceutical R&D Model - Business Wire","headline":"Centessa Pharmaceuticals Launches with $250 Million Series A Financing and Unveils a New Kind of Pharmaceutical R&D Mode","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"phase_1":1,"phase_2":1},"enrichmentLevel":3,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":{"source":"sec_edgar+yahoo","revenue":15000000,"revenuePeriod":"2025-12-31","revenueHistory":[{"value":15000000,"period":"2025-12-31"},{"value":0,"period":"2024-12-31"},{"value":6853000,"period":"2023-12-31"},{"value":0,"period":"2022-12-31"}],"grossProfit":null,"grossProfitHistory":[],"rdSpend":null,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":-197532000,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":61299000,"cashHistory":[],"totalAssets":687495000,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[]},"ciks":null,"lastFiledAt":null},"yahoo":null}